Company: IMG
Filing Date: 2025-07-30
Form Type: 10-K/A
Source: 0001641172-25-021542
Chunk: 76

Company: CIMG Inc.
Filing Date: 2025-07-30
Form: 10-K/A
Chunk 76
---
 year ended September 30, 2024, we focused on the introduction of our first health series in Asia, the Maca Series, which includes Maca Peptide Coffee, Maca-Noni, Maca Purified Powder and Maca Wine. All of the products from the Maca Series contains maca green purification factors, which are green purification of maca plants and pure natural products.

Cost of sales and gross margin

|                     |     | Year ended September 30, |      2024 |   |     |   |      2023 |    |     | Change | Dollars |   |     |     | %       |    |
|:--------------------|:----|:-------------------------|----------:|:--|:----|:--|----------:|:---|:----|:-------|--------:|:--|:----|:----|:--------|:---|
| Cost of sales       |     | $                        | 1,898,122 |   |     | $ | 1,968,785 |    |     | $      | (70,663 | ) |     |     | (3.59   | )% |
| Gross profit (loss) |     | $                        |    32,169 |   |     | $ |  (210,817 | )  |     | $      | 242,986 |   |     |     | (115.26 | )% |
| Gross margin %      |     |                          |      1.69 | % |     |   |    (10.71 | )% |     |        |         |   |     |     |         |    |

For the year ended September 30,
2024, our cost of sales totaled $1,898,122, as compared to cost of sales for the year ended September 30, 2023 of $1,968,785,
representing a 3.59% decrease. This is mainly due to the reduction in material and labor costs related to sales. For the year ended
September 30, 2024, our total gross profit was $32,169, while the gross loss for the year ended September 30, 2023 was $210,817.
This is also mainly due to the reduction in material and labor costs related to sales. The gross profit margin for the year ended
September 30, 2024 was 1.69%, and for the fiscal year